Heart News and Research

RSS

Vioxx safe enough for Canadian market says health panel

A canadian health advisory panel says that Merck's arthritis drug Vioxx should be allowed to go on sale again in the country, 10 months after the company withdrew the blockbuster painkiller over reports that it increased the risk of heart disease.

11 Jul 2005

Genes decide the shape you're in!

According to a study by researchers at the Lawrence Berkeley National Laboratory of identical twins, the reason why some people can eat all the chocolate and chips they want and not increase their cholesterol levels, is all down to their genes.

11 Jul 2005

Low dose birth control pill raises heart attack risk, especially in some women

A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.

11 Jul 2005

Fat in the bloodstream linked to heart attacks

New research, by Dr. Sotirios Tsimikas of the University of California, San Diego, has produced the first convincing evidence that a type of fat in the bloodstream can trigger the earliest conditions that lead to clogged blood vessels, the highest cause of heart attacks.

7 Jul 2005

Researchers clarifiy role of Notch protein in T-cell development

Researchers at the University of Pennsylvania School of Medicine have recently clarified the role of the Notch protein in T-cell development. T cells are required for many aspects of immunity, including fighting viral infections, providing cancer surveillance, and regulating multiple aspects of the immune response.

6 Jul 2005

Vitamin E fails to deliver benefits for major cardiovascular events or cancer

In an article in the July 6 JAMA, I-Min Lee, M.B.B.S., Sc.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues analyzed data from the vitamin E component of the Women's Health Study, which tested whether vitamin E supplementation decreases the risk of cardiovascular disease and cancer among healthy women.

6 Jul 2005

Research discovers new deadly link to sickle cell disease

A new study led by a researcher at Children's Hospital & Research Center at Oakland is the first to find that an amino acid deficiency in sickle cell disease is the result of hemolysis, a process where red blood cells rupture and release their contents into the blood stream. Low availability of the amino acid arginine is associated with lung disease and death in adult sickle cell patients.

6 Jul 2005

Having normal blood pressure may prolong life

People in their 50s who have normal blood pressure could live up to five years longer than those with hypertension (high blood pressure), an international study has found.

6 Jul 2005

Study details safety and efficacy of new Merci Retriever treatment for stroke patients

The recently released July issue of "Stroke," the official journal of the American Stroke Association, published new data on the safety and efficacy of the Merci Retriever System, the first medical device cleared by the FDA to remove blood clots from the brain in patients suffering an ischemic stroke.

6 Jul 2005

Aspirin can help prevent heart disease, but vitamin E no protection against cancer

It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.

6 Jul 2005

Antidepressants will cheer you up and stop a repeat heart attack

According to the National Institute of Mental Health, depression and heart disease have long been associated, and one can often lead to the other.

6 Jul 2005

Obese older women may be more prone to frailty

Obesity is associated with frailty in obese older women, according to a recent study published in the Journal of the American Geriatrics Society.

6 Jul 2005

Experimental treatment shown to reverse the loss of nerve fibres in Parkinson's Disease

Analysis of the brain of a patient suffering from Parkinson's Disease has shown that the experimental treatment he received caused regrowth of the nerve fibres that are lost in this disease. The findings are reported in the July issue of Nature Medicine.

6 Jul 2005

Vasodilators first choice for some heart patients

Few front-line medications exist for treating hospitalized patients with acute decompensated heart failure, a stage of heart failure marked by heightened severity and often-lengthy hospital stays with frequent readmissions. Now, a study suggests the list of preferred drugs for treating the disease might be even shorter.

6 Jul 2005

Call for greater use of angiograms in Canada

More tests need to be prescribed to save and prolong the lives of Canadians living with coronary artery disease, says a study released from the University of Alberta.

6 Jul 2005

G8 must focus on healthcare to save millions of lives

Millions of people are dying in the developing world because of poor access to cheap medicines and basic healthcare, the BMA says today (Wednesday, 6 July, 2005) ahead of the G8 summit.

6 Jul 2005

Vitamin E supplements do not protect healthy women against heart attacks and stroke

Vitamin E supplements do not protect healthy women against heart attacks and stroke, according to new results from the Women's Health Study, a long-term clinical trial of the effect of vitamin E and aspirin on both the prevention of cardiovascular disease and of cancer.

5 Jul 2005

Television in the bedroom bad for kids, computer good

A study of elementary school students found that children who had television sets in their bedrooms scored significantly lower on school achievement tests than children without TVs in their bedrooms.

5 Jul 2005

Withdrawn experimental drug found to reverse Parkinson's brain damage

Neuroscientists at Frenchay hospital in Bristol have discovered that an experimental drug for Parkinson's disease has been shown to trigger new nerve growth in the brain, the first time any treatment has been found to reverse the brain damage caused by the condition.

5 Jul 2005

NitroMed have launched BiDil for the treatment of heart failure in black patients

NitroMed, Inc. announced today that BiDil® (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black patients as an adjunct to current standard therapies.

4 Jul 2005